Compare Huntington Bancshares Incorporated (HBAN) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Huntington Bancshares Incorporated vs Regeneron Pharmaceuticals Inc — how do they compare? Huntington Bancshares Incorporated trades at $17.94 (market cap $35.93B), while Regeneron Pharmaceuticals Inc trades at $796.8 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 2.3× Huntington Bancshares Incorporated's market cap, and Huntington Bancshares Incorporated pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| HBAN | REGN | |
|---|---|---|
Market Cap | $35.93B | $82.06B |
Sector | Financials | Health |
52-Week High | $19.27 | $812.27 |
52-Week Low | $15.02 | $555.51 |
Dividend Yield | 3.49% | 0.47% |
Enterprise Value | — | $76.77B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HBAN trades at $17.60, up 0.28% today, with a bullish technical signal from moving averages and a consensus analyst price target of $19.78. Recent Q2 2026 earnings met estimates with EPS of $0.33, supported by net interest and fee income growth. The company targets an 18-19% ROTCE by 2027, though rising deposit costs present headwinds.
The outlook is cautiously optimistic, with valuation metrics like a P/E of 13.68 appearing reasonable. Upside potential exists if revenue growth and efficiency targets are met, but risks include margin pressure from higher funding costs and mixed earnings history. Institutional sentiment is balanced with 44.68% buy ratings.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Huntington Bancshares Incorporated
Huntington Bancshares is a regional bank holding company headquartered in Columbus, Ohio. The bank has a network of branches and ATMs across eight Midwestern states. Founded in 1866, Huntington National Bank and its affiliates provide consumer, small-business, commercial, treasury management, wealth management, brokerage, trust, and insurance services. Huntington also provides auto dealer, equipment finance, national settlement, and capital market services that extend beyond its core states.
Read more on HBAN →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
